Meeder Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.55M | Sell |
|
|||||
|
2025
Q2 | $2.96M | Buy |
|
|||||
|
2025
Q1 | $12.7K | Sell |
|
|||||
|
2024
Q4 | $21.4K | Sell |
|
|||||
|
2024
Q3 | $214K | Buy |
|
|||||
|
2024
Q2 | $28.4K | Sell |
|
|||||
|
2024
Q1 | $232K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.5K | Sell |
|
|||||
|
2023
Q1 | $3.97M | Sell |
|
|||||
|
2022
Q4 | $3.51M | Sell |
|
|||||
|
2022
Q3 | $4.18M | Sell |
|
|||||
|
2022
Q2 | $4.19M | Buy |
|
|||||
|
2022
Q1 | $4.53M | Sell |
|
|||||
|
2021
Q4 | $9.21M | Sell |
|
|||||
|
2021
Q3 | $10.2M | Buy |
|
|||||
|
2021
Q2 | $8.5M | Sell |
|
|||||
|
2021
Q1 | $8.08M | Buy |
|
|||||
|
2020
Q4 | $191K | Sell |
|
|||||
|
2020
Q3 | $2.7M | Buy |
|
|||||
|
2020
Q2 | $2.97M | Sell |
|
|||||
|
2020
Q1 | $2.33M | Sell |
|
|||||
|
2019
Q4 | $3.71M | Buy |
|
|||||
|
2019
Q3 | $185K | Sell |
|
|||||
|
2019
Q2 | $325K | Sell |
|
|||||
|
2019
Q1 | $5.88M | Buy |
|
|||||
|
2018
Q4 | $4.85M | Buy |
|
|||||
|
2018
Q3 | $3.28M | Buy |
|
|||||
|
2018
Q2 | $583K | Buy |
|
|||||
|
2018
Q1 | $307K | Sell |
|
|||||
|
2017
Q4 | $549K | Sell |
|
|||||
|
2017
Q3 | $1.4M | Buy |
|
|||||
|
2017
Q2 | $642K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $87K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $127K | Sell |
|
|||||
|
2015
Q4 | $529K | Buy |
|